Japan Patent Office

Shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI), a bio-therapeutics company focusing on the treatment of multiple ischemic and inflammatory conditions, were trading higher by more than 7 percent early Wednesday morning after the company announced it was granted two key cell therapy patents....